Analysis of cell death by flow cytometry after 16 h bortezomib treatment demonstrated that Cbfb+/56MFbxo9−/− tumor cells trended toward increased sensitivity compared to Cbfb+/56MFbxo9+/+ tumor cells, though a longer treatment time is required to achieve statistical significance (Figure 7F). Here, CBFB is linked to neoplasm.